ZDNET's key takeaways A survey by McKinsey examines the impact of AI on the workforce.The adoption of AI is causing both ...

In patients with preserved heart function after a heart attack, beta-blockers did not improve outcomes, according to a ...

The Association of Licensed Telecommunications Operators of Nigeria (ALTON) has warned that the proposed National Digital ...

A 44-year-old rickshaw driver from Thane developed dementia-like symptoms caused by vitamin B12 deficiency. Early diagnosis and treatment reversed his memory loss, highlighting the importance of ...

A new study suggests low levels of physical activity could protect the brain from Alzheimer’s disease – but not the way ...

Attorney General Pamela Bondi on Monday defended a controversial Trump administration proposal to eliminate the ATF and merge its functions into the Drug Enforcement Administration. The plan, outlined ...

Japanese researchers found that lecanemab, an amyloid-clearing drug for Alzheimer’s, does not improve the brain’s waste clearance system in the short term. This implies that nerve damage and impaired ...

RSS chief Mohan Bhagwat recently said that the organisation does not need registration because its work operates within the ...

ISLAMABAD: Senior Puisne Judge of the Supreme Court Justice Syed Mansoor Ali Shah has stated that the proposed Federal ...

The death of Miami-Dade Deputy Devin Jaramillo in the line of duty has left the community reeling from an unspeakable act of violence and asking how a routine traffic crash ended in what the Sheriff’s ...

Chronic kidney disease now ranks as the ninth leading cause of death globally, affecting 788 million people worldwide, according to major health study.

Scientists have identified a new drug that safeguards nerve cells harmed by 'one of the cruellest diseases', providing hope ...